OpenCapital
Earnings
Stock Screener
Metrics
/
Stocks
Connect AI
Toggle navigation menu
Stocks
Neurocrine Biosciences
Cash Flow Statement
Pre-tax Gain on Disposal of Business
Operating
Pre-tax Gain on Disposal of Business
Export Chart
Analysis
Statement
Cash Flow Statement
Section
Operating
First reported
Q1 2025
Last reported
Q1 2026
May 5, 2026
Metric ID:
rtx_gain_on_disposal_of_business_pretax
Historical Data
2 periods
Quarterly
Q1 '25
Q1 '26
Value
$0.00
$28.60M
Range
$0.00 – $28.60M
Frequently Asked Questions
What is Neurocrine Biosciences's pre-tax gain on disposal of business?
Neurocrine Biosciences (NBIX) reported pre-tax gain on disposal of business of $28.60M in Q1 2026.